Showing results (1-10 of 207) with videos related to
Sort By:
Pageof 21
Diabetes & Metabolism|June 22, 2013
What is the phenotype of patients with gastrointestinal intolerance to metformin?M P Hermans, S A Ahn, M F RousseauDiabetes & Metabolism|December 15, 2010
Statin therapy and cataract in type 2 diabetesM P Hermans, S A Ahn, M F RousseauDiabetic Medicine : a Journal of the British Diabetic Association|December 17, 2009
Handedness, insulin sensitivity and pancreatic B-cell function in Type 2 diabetesM P Hermans, S A Ahn, P L Selvais, et al.Diabetic Medicine : a Journal of the British Diabetic Association|June 12, 2010
Do high ferritin levels confer lower cardiovascular risk in men with Type 2 diabetes?M P Hermans, S A Ahn, K D Amoussou-Guenou, et al.Clinical Biochemistry|June 14, 2014
Measurement of Galectin-3 with the ARCHITECT assay: Clinical validity and cost-effectiveness in patients with heart failureD Gruson, M Mancini, S A Ahn, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|December 25, 2013
Galectin-3 testing: validity of a novel automated assay in heart failure patients with reduced ejection fractionD Gruson, M Mancini, S A Ahn, et al.Peptides|December 8, 2009
Circulating levels of stress associated peptide Urocortin in heart failure patientsD Gruson, S A Ahn, J M Ketelslegers, et al.Clinical Biochemistry|December 19, 2012
Comparison between intact and bioactive parathyroid hormone assays in patients with severe heart failureD Gruson, T Lepoutre, S A Ahn, et al.Journal of Endocrinological Investigation|March 7, 2012
Increased circulating concentrations of bioactive PTH 1-84 in patients with heart failureD Gruson, T Lepoutre, S A Ahn, et al.Peptides|December 21, 2005
Circulating urotensin II levels in moderate to severe congestive heart failure: its relations with myocardial function and well established neurohormonal markersD Gruson, M F Rousseau, S A Ahn, et al.Pageof 21